Outlook Therapeutics, Inc. (OTLK) Form 8-K — Sep 30, 2026
Outlook Therapeutics received a Nasdaq notice on September 25, 2026 because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The notice has no immediate effect on the listing. The company has 180 days, until March 24, 2027, to regain compliance by closing at or above $1.00 for at least ten consecutive business days.
Key figures
- Minimum bid price
- $1.00
- Compliance deadline
- 2027-03-24
- Days to regain compliance
- 180
- Consecutive business days below minimum
- 30
- Required consecutive days at or above 1usd
- 10
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.